TAM
MDT icon

Titleist Asset Management’s Medtronic MDT Stock Holding History

Titleist Asset Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,809
Closed -$366K – 408
2025
Q4 		$366K Buy
3,809
+9
+0.2% +$874 0.03% 272
2025
Q3 		$362K Sell
3,800
-1,904
-33% -$175K 0.03% 237
2025
Q2 		$497K Buy
5,704
+17
+0.3% +$1.44K 0.05% 205
2025
Q1 		$511K Sell
5,687
-990
-15% -$88.6K 0.06% 187
2024
Q4 		$533K Sell
6,677
-1,390
-17% -$120K 0.06% 187
2024
Q3 		$726K Buy
8,067
+1,457
+22% +$123K 0.1% 140
2024
Q2 		$520K Buy
6,610
+420
+7% +$34.4K 0.08% 162
2024
Q1 		$539K Sell
6,190
-1,985
-24% -$169K 0.09% 146
2023
Q4 		$673K Sell
8,175
-331
-4% -$25.2K 0.12% 123
2023
Q3 		$667K Buy
8,506
+107
+1% +$8.96K 0.14% 125
2023
Q2 		$740K Sell
8,399
-213
-2% -$18.3K 0.15% 117
2023
Q1 		$694K Buy
+8,612
New +$702K 0.15% 113

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Titleist Asset Management's MDT Position: Q1 2026 in Review

Titleist Asset Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,809 shares — an estimated $366K sold.

Titleist Asset Management first reported a position in MDT in Q1 2023 and held it in 12 quarters. The position peaked at $740K in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Titleist Asset Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Titleist Asset Management sold 3,809 Medtronic shares in Q1 2026, an estimated $366K.
  • Titleist Asset Management first reported a position in Medtronic in Q1 2023 and held it in 12 quarters.
  • Titleist Asset Management's Medtronic position peaked at $740K in Q2 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Titleist Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.